S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Greek authorities rescue 91 migrants from river islet on border with Turkey
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
Stock market today: Asian stocks follow Wall St up after strong US jobs report
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Greek authorities rescue 91 migrants from river islet on border with Turkey
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
Stock market today: Asian stocks follow Wall St up after strong US jobs report
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Greek authorities rescue 91 migrants from river islet on border with Turkey
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
Stock market today: Asian stocks follow Wall St up after strong US jobs report
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Greek authorities rescue 91 migrants from river islet on border with Turkey
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
Stock market today: Asian stocks follow Wall St up after strong US jobs report
NASDAQ:ASNS

Arsanis (ASNS) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$2.65
$3.23
50-Day Range
$3.11
$3.11
52-Week Range
$1.15
$28.69
Volume
31,653 shs
Average Volume
177,768 shs
Market Capitalization
$5.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ASNS stock logo

About Arsanis (NASDAQ:ASNS) Stock

X4 Pharmaceuticals, Inc. operates as a biotechnology company, which engages in developing human antibodies for treating infectious diseases. The company focuses on restoring healthy immune system function by developing novel therapeutics for the treatment of rare diseases. Its products in pipeline include X4P-001, X4P-002, and X4P-003. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan and is headquartered in Cambridge, MA.

Receive ASNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arsanis and its competitors with MarketBeat's FREE daily newsletter.

ASNS Stock News Headlines

Actelis Networks Inc (ASNS)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Actelis Networks Reports Fiscal First Quarter 2023
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Actelis Networks Reports Fiscal Full Year 2022
Actelis Networks Inc
See More Headlines


ASNS Company Calendar

Last Earnings
11/09/2018
Today
6/04/2023
Next Earnings (Estimated)
8/10/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Communications equipment, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:ASNS
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-10,980,000.00
Pretax Margin
-93.50%

Debt

Sales & Book Value

Annual Sales
$8.83 million
Book Value
$0.73 per share

Miscellaneous

Free Float
1,642,000
Market Cap
$5.53 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Paula S. Ragan
    President, Chief Executive Officer & Director
  • Adam S. Mostafa
    Chief Financial Officer & Treasurer
  • Celeste DiJohnson
    Vice President-Clinical Operations
  • Mary DiBiase
    Vice President-Technical Operations & Quality
  • Tarek Ebrahim
    Vice President-Medical Affairs & Rare Disease













ASNS Stock - Frequently Asked Questions

Are investors shorting Arsanis?

Arsanis saw a increase in short interest in May. As of May 15th, there was short interest totaling 52,800 shares, an increase of 214.3% from the April 30th total of 16,800 shares. Based on an average daily trading volume, of 241,300 shares, the days-to-cover ratio is presently 0.2 days. Currently, 4.0% of the company's shares are short sold.
View Arsanis' Short Interest
.

When is Arsanis' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our ASNS earnings forecast
.

How were Arsanis' earnings last quarter?

Arsanis, Inc. (NASDAQ:ASNS) released its earnings results on Friday, November, 9th. The company reported ($7.60) EPS for the quarter, missing analysts' consensus estimates of ($7.40) by $0.20. Arsanis had a negative net margin of 93.50% and a negative trailing twelve-month return on equity of 183.07%.

When did Arsanis' stock split?

Arsanis shares reverse split on the morning of Wednesday, April 19th 2023. The 1-10 reverse split was announced on Wednesday, April 19th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, April 19th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of Arsanis own?
When did Arsanis IPO?

(ASNS) raised $15 million in an initial public offering on Friday, May 13th 2022. The company issued 3,000,000 shares at $4.00-$6.00 per share. Boustead Securities acted as the underwriter for the IPO.

What is Arsanis' stock symbol?

Arsanis trades on the NASDAQ under the ticker symbol "ASNS."

What is Arsanis' stock price today?

One share of ASNS stock can currently be purchased for approximately $2.85.

How much money does Arsanis make?

Arsanis (NASDAQ:ASNS) has a market capitalization of $5.53 million and generates $8.83 million in revenue each year. The company earns $-10,980,000.00 in net income (profit) each year or ($4.79) on an earnings per share basis.

How can I contact Arsanis?

Arsanis' mailing address is 890 WINTER STREET SUITE 230, WALTHAM MA, 02451. The official website for the company is www.arsanis.com. The company can be reached via phone at (857) 529-8300 or via email at ir@arsanis.com.

This page (NASDAQ:ASNS) was last updated on 6/5/2023 by MarketBeat.com Staff

My Account -